Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report

Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report

Xiaoli Zhao,1,2 Mengze Hao,1,2 Xiaoyu Zhang,1,2 Jialin Wei,1,2 Sizhou Feng,1,2 Yi He,1,2 Erlie Jiang,1,2 Mingzhe Han1,2 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseas...

Full description

Bibliographic Details
Main Authors: Zhao X, Hao M, Zhang X, Wei J, Feng S, He Y, Jiang E, Han M
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:OncoTargets and Therapy
Subjects:
entrectinib
acute myeloid leukemia
etv6::ntrk3
allogeneic hematopoietic stem cell transplantation
Online Access:https://www.dovepress.com/post-hsct-maintenance-treatment-using-entrectinib-for-an-aml-patient-a-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/post-hsct-maintenance-treatment-using-entrectinib-for-an-aml-patient-a-peer-reviewed-fulltext-article-OTT

Similar Items